Insmed Delivers Rare Disappointment as Brinsupri Flops in Mid-Stage Rhinosinusitis Study on December 19, 2025 acquisition brensocatib Brinsupri Chronic sinusitis DPP1 inhibitor Insmed mid-stage trial Nasal inflammation Nasal Polyps stocks trial failure +
FDA Considers Noninvasive Endpoint for MASH Trials, Boosts Biotech Shares on August 28, 2025 Altimmune Biological Markers Clinical Trials Inventiva Liver diseases Madrigal Pharmaceuticals MASH Noninvasive Endpoint stocks United States Food and Drug Administration Viking Therapeutics +
Three-Month Drought in U.S. Biotech IPOs: Recent Developments and Context on May 16, 2025 Droughts IPO Market stocks +
Biotech stocks plunge and industry figures left to wonder after Prasad's FDA appointment on May 07, 2025 Appointments Cell Therapy figures Industry Market Prasad stocks United States Food and Drug Administration +
FDA Shakeup: Peter Marks' Resignation Rattles Biotech Industry on March 31, 2025 Peter Marks regulatory uncertainty resignation stocks United States Food and Drug Administration +